27 results
8-K
EX-10.1
CLSD
Clearside Biomedical Inc
8 Feb 24
Clearside Biomedical Announces Pricing of $15 Million Registered
5:05pm
to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case … as would not have or reasonably be expected to result in a Material Adverse Effect.
(m) Environmental Laws. The Company and its Subsidiaries (i
8-K
EX-10.1
CLSD
Clearside Biomedical Inc
12 May 23
Entry into a Material Definitive Agreement
4:11pm
subsidiaries or (iii) relating to environmental or discrimination matters, where in any such case (A) there is a reasonable possibility that such action … conducted evaluations of the effectiveness of its disclosure controls as required by Rule 13a-15 of the Exchange Act.
(cc)Compliance with Environmental Laws
8-K
EX-99.1
nokdodgzsm17vq2vk
8 Jan 21
Securities Purchase Agreement
8:19am
D
4yqyjxof vny8o
4 Dec 19
$3.35M in equity, sold $3.35M, 3 investors
4:07pm
8-K
EX-10.1
n2okm0qckii6ukreq1sk
25 Nov 19
Entry into a Material Definitive Agreement
8:15am
10-K
o2ofbbk6p24if4l
16 Mar 17
Annual report
12:00am